Welcome to our dedicated page for Flexible Solutn news (Ticker: FSI), a resource for investors and traders seeking the latest updates and insights on Flexible Solutn stock.
Flexible Solutions International (FSI) delivers specialty chemical innovations focused on water conservation and sustainable polymer technologies. This dedicated news hub provides investors and industry professionals with verified updates on the company's advancements in evaporation control solutions and eco-friendly chemical applications.
Access real-time announcements covering earnings disclosures, product development milestones, and strategic partnerships. Our curated collection includes regulatory filings, sustainability initiatives, and market expansion updates relevant to FSI's core operations in energy-efficient water treatments and biodegradable industrial polymers.
Key content categories span operational developments in evaporation reduction technologies, new patent filings, international distribution agreements, and environmental compliance achievements. Each update offers insights into how FSI addresses global challenges in resource conservation through scientifically validated chemical solutions.
Bookmark this page to maintain informed perspectives on FSI's progress in specialty chemicals. Combine regular visits with portfolio monitoring tools for comprehensive analysis of the company's market position and technological leadership.
Flexible Solutions International (NYSE-AMERICAN: FSI), a developer and manufacturer of biodegradable polymers and environmentally safe technologies, has announced its Q2 2024 revenue. The company reported a slight increase in sales, with top-line revenue rising from $10.331 million in Q2 2023 to $10.528 million in Q2 2024, representing a 2% year-over-year growth.
Complete financial results will be released on August 14, 2024, after market close, coinciding with the company's SEC second quarter filings. A conference call is scheduled for August 15, 2024, at 8:00 am Pacific Time (11:00 am Eastern Standard Time) to discuss the results.
Flexible Solutions International (NYSE-AMERICAN: FSI) announced a significant capital expenditure to acquire a production line for vial filling of injectable drugs such as GLP1 for weight loss. The $2.5 million investment secures a nearly-unused production line capable of producing 22.5 million vials per year, reducing the typical wait time and cost for such equipment. The company aims to leverage its existing clean room skills from its food/nutrition division to enter the high-risk, high-reward drug compounding market. CEO Dan O’Brien emphasized the need for de-risking this venture by securing sales and potentially partnering with experienced players in the industry. The company plans to proceed only if the benefits to shareholders outweigh the risks, with a minimum one-year timeframe before production can commence, subject to regulatory approvals.
Flexible Solutions International (FSI) has released its financial results for Q1 2024. The company reported sales of $9.22 million, a decrease of 6% from the $9.85 million in Q1 2023.
Net income fell to $457,226 ($0.04 per share) from $884,369 ($0.07 per share) in the previous year, due to higher costs and one-time expenses related to the closure of its Naperville R&D facility.
Operating cash flow for Q1 2024 was $1.34 million ($0.11 per share), down from $1.73 million ($0.14 per share) in Q1 2023. CEO Daniel B. O’Brien highlighted the progress in operational streamlining and new opportunities in the food and nutraceutical markets expected to drive revenue in 2024.
A conference call is scheduled for May 16, 2024, at 11:00 AM Eastern Time.
FAQ
What is the current stock price of Flexible Solutn (FSI)?
What is the market cap of Flexible Solutn (FSI)?
